Browse Non-Hodgkin's lymphomas topic

Care and treatment subtopic

Articles 1-54 out of 54 article(s) Title Author Type Date Words The Addition of VELCADE[R] (Bortezomib) for Injection to Novel Combination Delivers Promising Results in Patients with Non-Hodgkin's Lymphoma. Dec 8, 2009 1506 Allos Therapeutics' FOLOTYN[TM] Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma. Dec 8, 2009 1016 Allos Therapeutics' FOLOTYN[TM] Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant. Dec 7, 2009 1700 SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH. Dec 7, 2009 1069 Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN[TM] (pralatrexate injection). Dec 4, 2009 1180 Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting. Dec 3, 2009 1259 Granulocytic sarcoma of the nasal cavity: a case report. Gorman, Mary; Ahmed, Khwaja Asif; Pallera, Arnel; Samant, Sandeep Case study Nov 1, 2009 1654 Malignant lymphoma of the testis: a study of 12 cases. Lantz, Andrea G.; Power, Nicholas; Hutton, Brian; Gupta, Rekha Clinical report Oct 1, 2009 3173 Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN[TM] (pralatrexate) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. Sep 2, 2009 1233 Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. Aug 10, 2009 472 The Addition of VELCADE[R] (Bortezomib) for Injection to New and Standard Combinations Delivers Promising Results in Patients with Non-Hodgkin's Lymphoma. May 31, 2009 1557 Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status. May 26, 2009 1128 Allos Therapeutics Announces Final Results from Pivotal PROPEL Trial of Pralatrexate in Patients with Peripheral T-cell Lymphoma. Feb 3, 2009 1912 ZEVALIN Consolidation in First-Line Therapy in Patients with Non-Hodgkin's Lymphoma Resulted in a Progression-Free Survival of Greater Than 67 Months. Dec 8, 2008 1566 Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009. Dec 1, 2008 1638 RECRUITMENT COMPLETED IN OFATUMUMAB NHL PIVOTAL STUDY. Nov 1, 2008 390 Biovest and IDIS Announce Agreement to Launch Named-Patient Program for Anti-Cancer Vaccine in Europe. Oct 29, 2008 1445 Angiogenic non-Hodgkin T/natural killer (NK)-cell lymphoma: report of three cases. Martins-Filho, Rubens A.; Demarco, Ricardo C.; Valera, Fabiana C.P.; Shaletich, Catarina; Felix, Pau Clinical report Oct 1, 2008 2130 Radiotherapy-associated euthyroid Graves ophthalmopathy following floor-of-mouth surgery: a case report. Jaber, James J.; Thomas, Frank J.; Carfrae, Mathew J.; Galati, Lisa T. Clinical report Sep 1, 2008 2225 Preliminary Results from International Study Report That REVLIMID(R) Provides Responses for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma. Report Jun 14, 2008 536 Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma. Conference news Jun 5, 2008 965 Allos Therapeutics Announces Interim Data from Phase 1 Study of PDX in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma. Jun 5, 2008 1169 Investigational Studies Highlight Potential Utility of Zevalin Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma. Jun 1, 2008 604 Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL. Financial report May 19, 2008 1047 NCCN Updates Non-Hodgkin's Lymphoma Guidelines. Apr 22, 2008 607 Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma. Apr 22, 2008 1317 InNexus Biotechnology Announces Second Preclinical CandidateDXL702 (HER2/neu) Targeting Breast Cancer. Feb 19, 2008 797 Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH. Dec 10, 2007 1029 21. Efficacy and risk estimation of subcutaneous mistletoe treatment (Viscum album L. Pini) in patients with non-Hodgkin's lymphoma. Kuehn, J.J. Oct 1, 2007 297 22. Observation study on treatment with standardized Viscum album extracts (VA-E) in lymphocytic non-Hodgkin lymphoma (CLL): safety and course. Gutsch, J.; Rieger, S.; Schierholz, J.M.; Schlodder, D. Oct 1, 2007 486 Genzyme says phase 3 Mozobil trials meet primary endpoints for treating non-Hodgkin's lymphoma, multiple myeloma. Aug 1, 2007 474 Radiological case of the month: Vani Vijayakumar, MD; Raman Kansal, MD; and Atiar Rahman, MD, PhD. Vijayakumar, Vani; Kansal, Raman; Atiar, Rahman Case study Jul 1, 2007 746 Burkitt's lymphoma of the base of the tongue: a case report and review of the literature. Shibuya, Terry Y. Jun 1, 2007 2739 Diosynth Biotechnology Announces Agreement with VGX Pharmaceuticals for Process Development and Clinical Production of VGX-100 for the Treatment of Cancer. May 2, 2007 739 Clinical Data Launches PGxPredict(TM):RITUXIMAB on Schedule. Jan 30, 2007 1877 Biogen Idec Initiates Phase III Trial of Galiximab for Follicular Non-Hodgkin's Lymphoma. Jan 25, 2007 764 Biovest International's Phase 3 Therapy for Follicular Lymphoma Receives Independent Support From Newly Published Phase 2 Trial Data. Oct 19, 2006 807 Biovest International Therapy for Follicular Non-Hodgkin's Lymphoma Receives Rare Disease Designation from European Drug Agency. Oct 11, 2006 668 Primary B cell lymphoma of the external auditory canal. Hersh, David J. Sep 1, 2006 1320 MY 17-YR-OLD BABY GIRL; Cancer dad celebrates IVF success. Aug 29, 2006 305 Biovest International Gains Key Regulatory Approval for Clinical Trial Sites in Russia; Biovest to open 14 new clinical sites, accelerating patient recruitment. Jul 18, 2006 865 FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial:; Biovest Intends to Use Blood Test to File Application for Accelerated Approval. May 16, 2006 1074 Radiological case of the month: Pramod Gupta, MD; Qing Hua Zhao, MD; Mark Rosovsky, MD; Ashok Madan, MD. Gupta, Pramod; Zhao, Qing Hua; Rosovsky, Mark; Madan, Ashok Case study May 1, 2005 683 Stem cell transplants for cancer. Apr 1, 2005 352 Taking on a lethal blood cancer. Seppa, Nathan Brief Article Jan 1, 2005 151 Primary non-Hodgkin's lymphoma of the frontal sinus: case report and review of the literature. Butugan, Ossamu Jan 1, 2005 2848 Simultaneous presentation of Hodgkins and follicular non-Hodgkins lymphoma in a previously healthy male. Nelson, Douglas A. Brief Article Oct 1, 2004 263 Clinical trial update. Brief Article Jun 1, 2003 251 Health issues in survivors of childhood cancer. (Featured CME Topic: Pediatrics). Hudson, Melissa M. Sep 1, 2002 5084 Idec to reap huge benefits with drug's approval: Biotech; Zevalin expected to earn hundreds of millions in sales for local company. (Tech Talk). Webb, Marion Brief Article Feb 25, 2002 661 ONC3 Anemia of cancer in intermediate grade Non-Hodgkin's lymphoma (Ignhl) patients. (Oncology). Brief Article Dec 1, 2001 306 CD79[a.sup.+] T-Cell Lymphoblastic Lymphoma With Coexisting Langerhans Cell Histiocytosis: A Short Case Report and Review of the Literature. Li, Shiyong; Borowitz, Michael J. Jul 1, 2001 1713 Primary Paratesticular Lymphoma. Vega, Francisco; Medeiros, L. Jeffrey; Abruzzo, Lynne V. Mar 1, 2001 2818 An Unusual Variant of Composite Lymphoma. Thirumala, Seshadri; Esposito, Michael; Fuchs, Alexander Sep 1, 2000 1821